Robert Naclerio to Placebos
This is a "connection" page, showing publications Robert Naclerio has written about Placebos.
Connection Strength
0.302
-
Nasal challenge with allergen leads to maxillary sinus inflammation. J Allergy Clin Immunol. 2008 May; 121(5):1126-1132.e7.
Score: 0.078
-
Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma. J Allergy Clin Immunol Pract. 2019 Sep - Oct; 7(7):2447-2449.e2.
Score: 0.042
-
Intranasal beclomethasone reduces allergen-induced symptoms and superficial mucosal eosinophilia without affecting submucosal inflammation. Am J Respir Crit Care Med. 1998 Mar; 157(3 Pt 1):899-906.
Score: 0.039
-
Nasal provocation with allergen induces a secondary serum IgE antibody response. J Allergy Clin Immunol. 1997 Oct; 100(4):505-10.
Score: 0.038
-
Local nasal immunotherapy. Has the time come? Am J Respir Crit Care Med. 1995 Aug; 152(2):425-6.
Score: 0.032
-
Additional properties of cetirizine, a new H1 antagonist. Allergy Proc. 1991 May-Jun; 12(3):187-91.
Score: 0.024
-
The effect of a leukotriene antagonist on the early response to antigen. Otolaryngol Head Neck Surg. 1990 Mar; 102(3):219-24.
Score: 0.022
-
The effect of a topical tricyclic antihistamine on the response of the nasal mucosa to challenge with cold, dry air and histamine. J Allergy Clin Immunol. 1987 Apr; 79(4):599-604.
Score: 0.018
-
Low dose clemastine inhibits sneezing and rhinorrhea during the early nasal allergic reaction. Ann Allergy Asthma Immunol. 1997 Mar; 78(3):307-12.
Score: 0.009